Subdued Outlook For Bayer In 2017 Will Remain A Concern For Investors
Pharma & Healthcare / Germany / Tue 01 Aug, 2017
Bayer's lowered financial outlook for 2017 reflects a weaker-than-expected performance within the Consumer Healthcare business, which will remain a key concern among shareholders. As the US becomes increasingly saturated with consumer health products, further inroads into emerging markets and Europe will prove critical for Bayer towards securing